Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May-Jun:17:50-55.
doi: 10.1016/j.tmaid.2017.05.003. Epub 2017 May 6.

Long term health outcomes among Returned Peace Corps Volunteers after malaria prophylaxis, 1995-2014

Kathrine R Tan  1 , Susan J Henderson  2 , John Williamson  3 , Rennie W Ferguson  2 , Thomas M Wilkinson  2 , Paul Jung  2 , Paul M Arguin  3
Affiliations

Long term health outcomes among Returned Peace Corps Volunteers after malaria prophylaxis, 1995-2014

Kathrine R Tan et al. Travel Med Infect Dis. 2017 May-Jun.

Abstract

Background: A primary reason for non-adherence to malaria chemoprophylaxis is fear of latent side effects. We examined latent effects of malaria chemoprophylaxis among Returned Peace Corps Volunteers (RPCVs).

Methods: During July 18-September 16, 2016, RPCVs who served during 1995-2014 with an e-mail address in Peace Corps' RPCV database were invited to take an internet-based survey on malaria prophylaxis and medical diagnoses. "Good adherence" meant taking prophylaxis "as prescribed" or "most of the time." Prevalence of diseases diagnosed after Peace Corps service was compared between users and nonusers of each antimalarial using log-binomial regression.

Results: Of 8931 participants (11% response rate), 5055 (57%) took chemoprophylaxis. Initial chemoprophylaxis was mefloquine 59%, chloroquine 13%, doxycycline 16%, atovaquone-proguanil 4%, and "other" 8%. Sixty percent reported good adherence. Mefloquine users had the best adherence (67% good adherence). Prevalences of most diseases were similar between exposed and unexposed groups. Certain psychiatric diagnoses were slightly more likely among mefloquine users (PR 1.14, 95% CI [1.04-1.25], P = 0.0048). When excluding those with prior psychiatric illness, there were no differences in psychiatric diagnosis rates.

Conclusion: Malaria chemoprophylaxis use by Peace Corps Volunteers is safe. Avoiding mefloquine use in those with prior psychiatric illness can reduce psychiatric side effects.

Keywords: Antimalarial side effects; Long-term traveler; Malaria prophylaxis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors report no conflicts of interest.

References

    1. Centers for Disease Control and Prevention. CDC health information for international travel 2016. New York: Oxford University Press; 2016.
    1. Chen LH, Wilson ME, Schlagenhauf P. Prevention of malaria in long-term travelers. JAMA J Am Med Assoc 2006;296(18):2234–44. - PubMed
    1. Cunningham J, Horsley J, Patel D, Tunbridge A, Lalloo DG. Compliance with long-term malaria prophylaxis in British expatriates. Travel Med Infect Dis 2014;12(4):341–8. - PubMed
    1. Saunders DL, Garges E, Manning JE, et al. Safety, tolerability, and compliance with long-term antimalarial chemoprophylaxis in American soldiers in Afghanistan. Am J Trop Med Hyg 2015;93(3):584–90. - PMC - PubMed
    1. Landman KZ, Tan KR, Arguin PM. Adherence to malaria prophylaxis among peace corps volunteers in the Africa region, 2013. Travel Med Infect Dis 2015;13(1):61–8. - PMC - PubMed